Braz Vaidya, our Chief Scientist, is a strategic addition to our leadership team. With over two decades of experience in cutting-edge tissue culture and plant biotechnology, Braz has been involved in both national and international projects, positioning him as a key driver of innovation. His expertise will play a pivotal role in helping us achieve our ambitious goal of producing 5,000,000 tissue culture clones per month, solidifying our position as an industry leader and ensuring consistent growth in a rapidly expanding market.

Investors can be confident in Endless Biotech’s ability to deliver on its goals with the guidance of a world-class expert. Braz's contributions will accelerate our research and development capabilities, ensuring that we continue to lead in pioneering tissue culture technology while also exploring new growth avenues. His involvement strengthens our competitive edge and aligns perfectly with our long-term strategy for expansion and innovation.